Cargando…
AI in drug discovery and its clinical relevance
The COVID-19 pandemic has emphasized the need for novel drug discovery process. However, the journey from conceptualizing a drug to its eventual implementation in clinical settings is a long, complex, and expensive process, with many potential points of failure. Over the past decade, a vast growth i...
Autores principales: | Qureshi, Rizwan, Irfan, Muhammad, Gondal, Taimoor Muzaffar, Khan, Sheheryar, Wu, Jia, Hadi, Muhammad Usman, Heymach, John, Le, Xiuning, Yan, Hong, Alam, Tanvir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302550/ https://www.ncbi.nlm.nih.gov/pubmed/37396052 http://dx.doi.org/10.1016/j.heliyon.2023.e17575 |
Ejemplares similares
-
Antibody-drug conjugates in lung cancer: dawn of a new era?
por: Coleman, Niamh, et al.
Publicado: (2023) -
A lightweight CORONA-NET for COVID-19 detection in X-ray images
por: Hadi, Muhammad Usman, et al.
Publicado: (2023) -
AI in drug discovery: Applications, opportunities, and challenges
por: Bittner, Martin-Immanuel, et al.
Publicado: (2022) -
Current and future treatment options for MET exon 14 skipping alterations in non-small cell lung cancer
por: Hong, Lingzhi, et al.
Publicado: (2021) -
Toward explainable AI-empowered cognitive health assessment
por: Javed, Abdul Rehman, et al.
Publicado: (2023)